title: Response to "Effect of tissue plasminogen activator dose and interval on stroke severity".
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Demetrios J
authors.initials: DJ
authors.lastname: Sahlas
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Linda
authors.initials: L
authors.lastname: Gould
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Richard
authors.initials: R
authors.lastname: Swartz
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Naufal
authors.initials: N
authors.lastname: Mohammed
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Rhonda
authors.initials: R
authors.lastname: McNicoll-Whiteman
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Fahd
authors.initials: F
authors.lastname: Naufal
authors.affiliation: Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.
authors.forename: Wieslaw
authors.initials: W
authors.lastname: Oczkowski
mesh_terms: D002545:Brain Ischemia / Q000150:complications*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008297:Male; D020521:Stroke / Q000150:complications*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator